Status:
COMPLETED
International Hernia Mesh Registry
Lead Sponsor:
Ethicon, Inc.
Conditions:
Hernia
Eligibility:
All Genders
18+ years
Brief Summary
This is an open-label, multi-center, long-term, prospective hernia mesh registry. A minimum of 4,800 hernia patients will be enrolled from approximately 60 active sites globally
Detailed Description
Patients will be followed for 2-years post-implantation, in a post-market setting to help identify best practices leading to lower recurrence rates and decreases in chronic pain, associated with the h...
Eligibility Criteria
Inclusion
- Inclusion Criteria
- Patients must satisfy the following criteria before entering the registry:
- Provide written informed consent prior to surgery;
- Male or female patients that are \> 18 years of age;
- Be literate and able to understand a language available in the Registry Patient Questionnaires;
- Scheduled to receive a surgically implanted ETHICON synthetic mesh using any fixation method or a non-ETHICON synthetic mesh which must be fixated with SECURESTRAP® or SECURESTRAP® Open for repair of a hernia defect;
- Agree to provide long-term, outcomes data to Quintiles Outcome;
- Agree to provide contact information;
- Two or more pieces of the same mesh product sewn together will be considered as one mesh, and is therefore allowed in this registry
- Exclusion Criteria
- Patients who meet any of the following criteria will be excluded from participating in the registry:
- Patients that are \<18 years of age;
- Patients who have been entered into the registry previously;
- Employees of the investigator or registry center with direct involvement in the proposed registry or other studies under the direction of that investigator or registry center and employees of ETHICON;
- Patients suffering from and currently receiving medication for chronic pain (defined as suffering pain for greater than 3 months);
- Patients known to be suffering from pre-existing chronic depression;
- Patients currently known or suspected to abuse drugs or alcohol;
- Patients suffering from a terminal illness (e.g. cancer);
- Patients requiring multiple hernia repairs (including bilateral inguinal/femoral);
- Patients requiring any other (concomitant) surgical procedure;
- Patients suffering from an ongoing infection, sepsis, contaminated mesh or fistulas;
- Patients who require hiatal, paraesophageal or diaphragmatic hernia repair;
- Patients requiring two different types of meshes;
- Patients requiring two or more meshes not sewn together
- Patients scheduled to receive a surgically implanted biologic mesh product for repair of a hernia defect
Exclusion
Key Trial Info
Start Date :
September 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 25 2021
Estimated Enrollment :
5179 Patients enrolled
Trial Details
Trial ID
NCT00622583
Start Date
September 1 2007
End Date
January 25 2021
Last Update
June 5 2023
Active Locations (54)
Enter a location and click search to find clinical trials sorted by distance.
1
Florida Hospital Celebration Health
Celebration, Florida, United States, 34747
2
Center for Hernia Repair
Sarasota, Florida, United States, 34139
3
Steward Norwood Hospital
Norwood, Massachusetts, United States, 02062
4
University of Missouri-Columbia
Columbia, Missouri, United States, 65212